- 1.
Leowski J. Mortality from acute respiratory infections in children under 5 years of age: Global estimates.
World Health Statistics Quarterly. 1986;39:138–44. [
PubMed: 3751104]
- 2.
United Nations Inter Agency Group for Child Mortality Estimation. UNICEF, WHO, The World Bank, United Nations Population Division; New York: 2014. Levels and Trends in Child Mortality: Report 2014.
- 3.
- 4.
- 5.
- 6.
- 7.
- 8.
Chart booklet: Integrated Management of Childhood Illness (IMCI). Geneva: World Health Organization/The United Nation Children's Fund (UNICEF); 2008.
- 9.
- 10.
- 11.
Bang AT, Bang RA, Reddy HM. Home-based neonatal care: summary and applications of the field trial in rural Gadchiroli, India (1993 to 2003).
Journal of Perinatology. 2005;25:S108–S122. [
PubMed: 15791272]
- 12.
The Multi-Country Evaluation of IMCI Effectiveness, Cost and Impact (MCE) – Progress Report', May 2001–April 2002. Geneva: World Health Organization; 2002. (WHO/FCH/CAG/02.16)
- 13.
Aguilar AM, et al. Mortality Survey of Bolivia: The Final Report: Investigating and identifying the causes of death for children under five. Virginia: 1998. Published for USAID by the Basic Support for Institutionalizing Child Survival (BASICS) Project.
- 14.
Schumacher R, et al. Mortality Study in Guinea: Investigating the causes of death in children under 5. Virginia: 2002. Published by Save the Children and the Basic Support for Institutionalizing Child Survival (BASICS II) Project.
- 15.
Schellenberg JA, et al. Inequalities among the very poor. Health care for children in rural southern Tanzania.
Lancet. 2003;361:561–66. [
PubMed: 12598141]
- 16.
Kabra SK, Lodha R, Pandey RM. Antibiotics for community-acquired pneumonia in children.
Cochrane Database of Systematic Reviews. 2010. CD004874. [
PubMed: 20238334]
- 17.
- 18.
Haider BA, Saeed MA, Bhutta ZA. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months.
Cochrane Database of Systematic Reviews. 2008. CD:005976. [
PubMed: 18425930]
- 19.
Hazir T, et al. Clinical efficacy of 3 days versus 5 days of oral amoxicillin for treatment of childhood pneumonia: a multicentre double-blind trial.
Lancet. 2002;360:835–41. [
PubMed: 12243918]
- 20.
Agarwal G, et al. Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.
British Medical Journal. 2004;328:791. [
PMC free article: PMC383371] [
PubMed: 15070633]
- 21.
Consultative meeting to review evidence and research priorities in the management of acute respiratory infections. Geneva: World Health Organization; 29 September–1 October 2003. 2004. Geneva. (WHO/FCH/CAH/04.2)
- 22.
Pocket book of hospital care for children: Guidelines for the management of common illnesses. Geneva: World Health Organization; 2005. [
PubMed: 24006557]
- 23.
Straus W, et al. Antimicrobial resistance and clinical effectiveness of cotrimoxazole versus amoxicillin for pneumonia among children in Pakistan: randomised controlled trial.
Lancet. 1998;352:270–74. [
PubMed: 9690406]
- 24.
Addo-Yobo E, et al. Oral amoxicillin versus injectable penicillin for severe pneumonia in children aged 3 to 59 months: a randomised multicentre equivalency study.
Lancet. 2004;364:1141–8. [
PubMed: 15451221]
- 25.
Atkinson M, et al. A multicentre randomised controlled equivalence trial comparing oral amoxicillin and intravenous benzyl penicillin for community acquired pneumonia in children PIVOT Trial.
Thorax. 2007;62:1102–6. [
PMC free article: PMC2094276] [
PubMed: 17567657]
- 26.
Hazir T, et al. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial.
Lancet. 2008;371:49–56. [
PubMed: 18177775]
- 27.
Addo-Yobo E, et al. Outpatient treatment of children with severe pneumonia with oral amoxicillin in four countries: the MASS study.
Tropical Medicine and International Health. 2011;16:995–1006. [
PMC free article: PMC3154370] [
PubMed: 21545381]
- 28.
Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.
Clinical Infectious Diseases. 1998;26:1–10. [
PubMed: 9455502]
- 29.
Craig WA. Antimicrobial resistance issues of the future.
Diagnostic Microbiology and Infectious Diseases. 1996;25:213–7. [
PubMed: 8937847]
- 30.
Howie VM, Dillard R, Lawrence B. In vivo sensitivity test in otitis media: efficacy of antibiotics.
Pediatrics. 1985;75:8–13. [
PubMed: 3871251]
- 31.
Howie V. Eradication of bacterial pathogens from middle ear infections. Clinical Infectious Diseases. 1992;14(suppl 2):S209–11.
- 32.
Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media.
Pediatric Infectious Diseases Journal. 1993;12:973–5. [
PubMed: 8108222]
- 33.
Dagan R, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Pediatric Infectious Diseases Journal. 1996;15:980–5. [
PubMed: 8933545]
- 34.
Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.
Pediatric Infectious Diseases Journal. 1996;15:255–9.38. [
PubMed: 8852915]
- 35.
Lieberthal AS, et al. The diagnosis and management of acute otitis media. American Academy of Pediatrics and American Academy of Family Physicians.
Pediatrics. 2013;131:e964–99. [
PubMed: 23439909] [
CrossRef]
- 36.
Fonseca W, et al. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia.
Antimicrobial Agents and Chemotherapy. 2003;47:997–1001. [
PMC free article: PMC149282] [
PubMed: 12604533]
- 37.
Valtonen M, et al. Comparison of amoxicillin given two and three times a day in acute respiratory tract infections in children.
Scandinavian Journal of Primary Health Care. 1986;4:201–4. [
PubMed: 3797879]
- 38.
Daschner FD, Behre U, Dalhoff A. Prospective clinical trial on the efficacy of amoxicillin administered twice or four times daily in children with respiratory tract infections.
Journal of Internal Medicine Research. 1981;9:274–6. [
PubMed: 7021263]
- 39.
Catchup Study Group. Clinical efficacy of cotrimoxazole versus amoxicillin twice daily for treatment of pneumonia: a randomized controlled clinical trial in Pakistan.
Archives of Diseases in Childhood. 2002;86:113–18. [
PMC free article: PMC1761064] [
PubMed: 11827905]
- 40.
Lassi ZS, et al. Systematic review on antibiotic therapy for pneumonia in children less than 59 months of age.
Archives of Diseases in Childhood. 2014;99:687–93. [
PubMed: 24431417]
- 41.
Duke T, et al. Chloramphenicol versus benzylpenicillin and gentamicin for the treatment of severe pneumonia in children in Papua New Guinea: a randomised trial.
Lancet. 2002;359:474–80. [
PubMed: 11853793]
- 42.
Asghar R, et al.
Severe Pneumonia Evaluation Antimicrobial Research Study Group. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2–59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
British Medical Journal. 2008;336:80–4. [
PMC free article: PMC2190277] [
PubMed: 18182412]
- 43.
Jeena P, et al.
Amoxicillin Penicillin Pneumonia International Study (APPIS Group). Failure of standard antimicrobial therapy in children aged 3–59 months with mild or asymptomatic HIV infection and severe pneumonia.
Bulletin of the World Health Organization. 2006;84:269–75. [
PMC free article: PMC2627320] [
PubMed: 16628299]
- 44.
Punpanich W, et al. Antibiotic and systemic therapies for pneumonia in human immunodeficiency virus (HIV)-infected and HIV-exposed children.
Journal of Infection in Developing Countries. 2012;6:109–19. [
PubMed: 22337838]
- 45.
Punpanich W, et al. Systematic review on the etiology and antibiotic treatment of pneumonia in human immunodeficiency virus-infected children.
Pediatric Infectious Diseases Journal. 2011;30:e192–202. [
PubMed: 21857264] [
CrossRef]
- 46.
Laufer MK. Observational cohort study of HIV-infected African children.
Pediatric Infectious Disease Journal. 2006;25:623–7. [
PubMed: 16804433]
- 47.
Jeena PM, Coovadia HM, Chrystal V.
Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants.
Annals of Tropical Paediatrics. 1996;16:361–8. [
PubMed: 8985536]
- 48.
- 49.
Simonds RJ, et al.
Pneumocystis carinii pneumonia among U.S. children with perinatally acquired HIV infection.
Journal of American Medical Association. 1993;270:470–3. [
PubMed: 8320786]
- 50.
Chokephaibulkit K.
Pneumocystis carinii severe pneumonia among human immunodeficiency virus-infected children in Thailand: the effect of a primary prophylaxis strategy.
Pediatric Infectious Disease Journal. 1999;18:147–52. [
PubMed: 10048687]
- 51.
Williams AJ, et al.
Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection.
AIDS. 2001;15:335–9. [
PubMed: 11273213]
- 52.
- 53.
Hadi A. Management of acute respiratory infections by community health volunteers: experience of Bangladesh Rural Advancement Committee (BRAC).
Bulletin of the World Health Organization. 2003;81:183–89. [
PMC free article: PMC2572422] [
PubMed: 12764514]
- 54.
Ghimire M, Pradhan YV, Maskey MK. Community based intervention for diarrhoeal diseases and acute respiratory infections in Nepal.
Bulletin of the World Health Organization. 2010;88:216–21. [
PMC free article: PMC2828786] [
PubMed: 20428390]
- 55.
Nsona H, et al. Scaling up integrated community case management of childhood illness: Update from Malawi.
American Journal of Tropical Medicine and Hygiene. 2012;87:54–60. [
PMC free article: PMC3748522] [
PubMed: 23136278]
- 56.
Bari A, et al. Community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Haripur district, Pakistan: a cluster randomised trial.
Lancet. 2011;2011(378):1796–803. [
PMC free article: PMC3685294] [
PubMed: 22078721]
- 57.
Soofi S, et al. Effectiveness of community case management of severe pneumonia with oral amoxicillin in children aged 2–59 months in Matiari district, rural Pakistan: a cluster-randomised controlled trial.
Lancet. 2012;379:729–37. [
PubMed: 22285055]
- 58.
- 59.
Chola L, Robberstad B. Estimating average inpatient and outpatient costs and childhood pneumonia and diarrhoea treatment costs in an urban health centre in Zambia.
Cost Effectiveness and Resources Allocation. 2009;7:16. [
PMC free article: PMC2770026] [
PubMed: 19845966]
- 60.
Hussain H, et al. Economic analysis of childhood pneumonia in Northern Pakistan.
Health Policy and Planning. 2008;23:438–42. [
PubMed: 18755733]
- 61.
Hussain H, et al. The cost of treatment for child pneumonias and meningitis in the Northern Areas of Pakistan.
The International Journal of Health Planning and Management. 2006;21:229–38. [
PubMed: 17044548]
- 62.
Lorgelly PK, et al. Oral versus i.v. antibiotics for community acquired pneumonia in children: a cost minimization analysis.
European Respiratory Journal. 2010;35:585–64. [
PubMed: 19717479]
- 63.
Madsen HO, et al. Costing of severe pneumonia in hospitalized infants and children aged 2–36 months, at a secondary and tertiary level hospital of a not-for-profit organization.
Tropical Medicine and International Health. 2009;14:1315–22. [
PubMed: 19719464]
- 64.
Ayieko P, et al. The economic burden of inpatient pediatric care in Kenya: household and provider costs for treatment of pneumonia, malaria and meningitis.
Cost Effectiveness and Resources Allocation. 2009;7:3. [
PMC free article: PMC2640355] [
PubMed: 19161598]
- 65.
Priority essential medicines for child survival. Copenhagen: The United Nations Children's Fund/World Health Organization; 2010.
- 66.
Grießmann K, et al. Dosing accuracy of measuring devices provided with antibiotic oral suspensions. Paediatric and Perinatal Drug Therapy. 2007;8:61–70.
- 67.
Falagas, et al. Inaccuracies in dosing with teaspoons and tablespoons.
The International Journal of Clinical Practice. 2010;64:1185–9. [
PubMed: 20653796]
- 68.
Monk PM, Ball PA. The accuracy of a paediatric dosing device. The Australian Journal of Hospital Pharmacy. 1997;27:323–324.
- 69.
Report of the informal expert meeting on dosage forms of medicines for children. Geneva: World Health Organization; 2008.
- 70.
